201
Views
18
CrossRef citations to date
0
Altmetric
Research Articles

Pharmacokinetics and brain targeting of trans-resveratrol loaded mixed micelles in rats following intravenous administration

ORCID Icon, , , , , & show all
Pages 300-307 | Received 01 Feb 2019, Accepted 11 Oct 2019, Published online: 27 Nov 2019

References

  • Abdel-Aleem GA, Khaleel EF, Mostafa DG, Elberier LK. 2016. Neuroprotective effect of resveratrol against brain ischemia reperfusion injury in rats entails reduction of DJ-1 protein expression and activation of PI3K/Akt/GSK3b survival pathway. Arch Physiol Biochem. 122(4):200–213.
  • Andrade S, Ramalho MJ, do Carmo Pereira M, Loureiro JA. 2018. Resveratrol brain delivery for neurological disorders prevention and treatment. Front Pharmacol. 9:1261.
  • Attia ABE, Ong ZY, Hedrick JL, Lee PP, Ee PLR, Hammond PT, Yang Y-Y. 2011. Mixed micelles self-assembled from block copolymers for drug delivery. Curr Opin Colloid Interface Sci. 16(3):182–194.
  • Balata GF, Essa EA, Shamardl HA, Zaidan SH, Abourehab MA. 2016. Self-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrol. Drug Des Devel Ther. 10:117.
  • Bertelli A, Giovannini L, Bernini W, Migliori M, Fregoni M, Bavaresco L, Bertelli A. 1996. Antiplatelet activity of cis-resveratrol. Drugs Exp Clin Res. 22(2):61–63.
  • Bhateria M, Ramakrishna R, Puttrevu SK, Yerrabelli S, Saxena AK, Bhatta RS. 2016. Pre-clinical investigation of plasma pharmacokinetics and biodistribution of a novel antithrombotic agent S002-333 in mice using LC–MS/MS. J Chromatogr B. 1031:154–162.
  • Chauhan AS. 2015. Dendrimer nanotechnology for enhanced formulation and controlled delivery of resveratrol. Ann NY Acad Sci. 1348(1):134–140.
  • Chen L, Sha X, Jiang X, Chen Y, Ren Q, Fang X. 2013a. Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation. Int J Nanomed. 8:73.
  • Chen Y, Sha X, Zhang W, Zhong W, Fan Z, Ren Q, Chen L, Fang X. 2013b. Pluronic mixed micelles overcoming methotrexate multidrug resistance: in vitro and in vivo evaluation. Int J Nanomed. 8:1463.
  • Choi YA, Yoon YH, Choi K, Kwon M, Goo SH, Cha J-S, Choi M-K, Lee HS, Song I-S. 2015. Enhanced oral bioavailability of morin administered in mixed micelle formulation with PluronicF127 and Tween80 in rats. Biol Pharmaceutical Bull. 38(2):208–217.
  • Ding J, Sun Y, Li J, Wang H, Mao S. 2017. Enhanced blood–brain barrier transport of vinpocetine by oral delivery of mixed micelles in combination with a message guider. J Drug Targeting. 25(6):532–540.
  • Gan CW, Feng S-S. 2010. Transferrin-conjugated nanoparticles of poly (lactide)-D-α-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood–brain barrier. Biomaterials. 31(30):7748–7757.
  • Gullotti E, Yeo Y. 2009. Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery. Mol Pharmaceutics. 6(4):1041–1051.
  • Hao J, Gao Y, Zhao J, Zhang J, Li Q, Zhao Z, Liu J. 2015. Preparation and optimization of resveratrol nanosuspensions by antisolvent precipitation using Box-Behnken design. AAPS PharmSciTech. 16(1):118–128.
  • Isailović BD, Kostić IT, Zvonar A, Đorđević VB, Gašperlin M, Nedović VA, Bugarski BM. 2013. Resveratrol loaded liposomes produced by different techniques. Innovat Food Sci Emerg Technol. 19:181–189.
  • Jadhav P, Bothiraja C, Pawar A. 2016. Resveratrol-piperine loaded mixed micelles: formulation, characterization, bioavailability, safety and in vitro anticancer activity. RSC Adv. 6(114):112795–112805.
  • Jin F, Wu Q, Lu Y-F, Gong Q-H, Shi J-S. 2008. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. Eur J Pharmacol. 600(1-3):78–82.
  • Johnson JJ, Nihal M, Siddiqui IA, Scarlett CO, Bailey HH, Mukhtar H, Ahmad N. 2011. Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res. 55(8):1169–1176.
  • Kabanov AV, Batrakova EV, Miller DW. 2003. Pluronic® block copolymers as modulators of drug efflux transporter activity in the blood–brain barrier. Adv Drug Delivery Rev. 55(1):151–164.
  • Kulkarni SA, Feng S-S. 2011. Effects of surface modification on delivery efficiency of biodegradable nanoparticles across the blood–brain barrier. Nanomedicine. 6(2):377–394.
  • Li J, Gao M, Wang H, Liu Q, Mao S. 2015. Optimization and in vitro characterization of resveratrol-loaded poloxamer 403/407 mixed micelles . Yao Xue Xue Bao. 50(8):1045–1051.
  • Li T-P, Wong W-P, Chen L-C, Su C-Y, Chen L-G, Liu D-Z, Ho H-O, Sheu M-T. 2017. Physical and pharmacokinetic characterizations of trans-resveratrol (t-Rev) encapsulated with self-assembling lecithin-based mixed polymeric micelles (sa LMPMs). Sci Rep. 7(1):10674.
  • Lin JH, Lu AY. 1997. Role of pharmacokinetics and metabolism in drug discovery and development. Pharmacol Rev. 49(4):403–449.
  • Meng X, Liu J, Yu X, Li J, Lu X, Shen T. 2017. Pluronic F127 and D-α-tocopheryl polyethylene glycol succinate (TPGS) mixed micelles for targeting drug delivery across the blood brain barrier. Sci Rep. 7(1):2964.
  • Meng X, Wang F, Li C. 2014. Resveratrol is neuroprotective and improves cognition in pentylenetetrazole-kindling model of epilepsy in rats. Indian J Pharm Sci. 76(2):125.
  • Neves AR, Martins S, Segundo MA, Reis S. 2016. Nanoscale delivery of resveratrol towards enhancement of supplements and nutraceuticals. Nutrients. 8(3):131.
  • Pandey KB, Rizvi SI. 2009. Protective effect of resveratrol on formation of membrane protein carbonyls and lipid peroxidation in erythrocytes subjected to oxidative stress. Appl Physiol Nutr Metab. 34(6):1093–1097.
  • Pandey KB, Rizvi SI. 2011. Anti-oxidative action of resveratrol: implications for human health. Arabian Journal of Chemistry. 4(3):293–298.
  • Pandita D, Kumar S, Poonia N, Lather V. 2014. Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol. Food Res Int. 62:1165–1174.
  • Pangeni R, Sahni JK, Ali J, Sharma S, Baboota S. 2014. Resveratrol: review on therapeutic potential and recent advances in drug delivery. Expert Opin Drug Delivery. 11(8):1285–1298.
  • Sawda C, Moussa C, Turner RS. 2017. Resveratrol for Alzheimer's disease. Ann N Y Acad Sci. 1403(1):142–149.
  • Saxena V, Hussain MD. 2013. Polymeric mixed micelles for delivery of curcumin to multidrug resistant ovarian cancer. J Biomed Nanotechnol. 9(7):1146–1154.
  • Shen H, Liu S, Ding P, Wang L, Ju J, Liang G. 2018. Enhancement of oral bioavailability of magnolol by encapsulation in mixed micelles containing pluronic F127 and L61. J Pharm Pharmacol. 70(4):498–506.
  • Simões SM, Figueiras AR, Veiga F, Concheiro A, Alvarez-Lorenzo C. 2015. Polymeric micelles for oral drug administration enabling locoregional and systemic treatments. Expert Opin Drug Delivery. 12(2):297–318.
  • Singh G, Pai RS. 2015. Trans-resveratrol self-nano-emulsifying drug delivery system (SNEDDS) with enhanced bioavailability potential: optimization, pharmacokinetics and in situ single pass intestinal perfusion (SPIP) studies. Drug Delivery. 22(4):522–530.
  • Švajger U, Jeras M. 2012. Anti-inflammatory effects of resveratrol and its potential use in therapy of immune-mediated diseases. Int Rev Immunol. 31(3):202–222.
  • Torchilin VP. 2002. PEG-based micelles as carriers of contrast agents for different imaging modalities. Adv Drug Delivery Rev. 54(2):235–252.
  • Trivedi R, Kompella UB. 2010. Nanomicellar formulations for sustained drug delivery: strategies and underlying principles. Nanomedicine. 5(3):485–505.
  • Vijayakumar MR, Kumari L, Patel KK, Vuddanda PR, Vajanthri KY, Mahto SK, Singh S. 2016. Intravenous administration of trans-resveratrol-loaded TPGS-coated solid lipid nanoparticles for prolonged systemic circulation, passive brain targeting and improved in vitro cytotoxicity against C6 glioma cell lines. RSC Adv. 6(55):50336–50348.
  • Walle T, Hsieh F, DeLegge MH, Oatis JE, Walle UK. 2004. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 32 (12):1377.
  • Wang S, Chen R, Morott J, Repka MA, Wang Y, Chen M. 2015. mPEG-b-PCL/TPGS mixed micelles for delivery of resveratrol in overcoming resistant breast cancer. Expert Opin Drug Delivery. 12(3):361–373.
  • Wei Z, Hao J, Yuan S, Li Y, Juan W, Sha X, Fang X. 2009. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int J Pharm. 376(1-2):176–185.
  • Wu X, Ge W, Shao T, Wu W, Hou J, Cui L, Wang J, Zhang Z. 2017. Enhancing the oral bioavailability of biochanin A by encapsulation in mixed micelles containing Pluronic F127 and Plasdone S630. Int J Nanomed. 12:1475.
  • Xu H, Yang P, Ma H, Yin W, Wu X, Wang H, Xu D, Zhang X. 2016. Amphiphilic block copolymers-based mixed micelles for noninvasive drug delivery. Drug Deliv. 23(8):3063–3071.
  • Yang C, Wu T, Qi Y, Zhang Z. 2018. Recent advances in the application of vitamin E TPGS for drug delivery. Theranostics. 8(2):464.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.